5 major failures that could have been transformative Lots of excuses, no positive results, this is what a $500K/year CEO delivers
1) functional drink, that was a corporate target for 2020
2) Y-BG, in 2020 a phase 1/2 clinical protocol was planned to be submitted in Q4 2020
https://www.ceapro.com/news/press-releases/detail/199/ceapro-inc-provides-update-on-development-of-an-inhalable)[/url
this appears to be in limbo now
3) NCC, that was a corporate target fof 2020
4) BG pill, if the Italian study was read before the MHI study began, protocol calling for satchets could have been used
5) CoQ10 license, that was a corporate target for H2 2023 (with the CRO gone, so are the so called "serious" discussions?)
OATS, you have the ability to change these results, vote NO to the sham merger, then VOTE out Gilles at the AGM, and we can push for a new CEO